🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Dr. Kilbridge's pioneering research found reading level is strongly linked to understanding prostate cancer terms. Most materials are written WAY above patient literacy levels #AccessibleHealthcare #PatientRights pubmed.ncbi.nlm.nih.gov/19307512/

#ASCO2025 Powerful letter from ASCO #DailyNews Editor Neeraj Agarwal, MD, FASCO “In the fight against cancer, we are united by purpose.” Thx for all your hard work & dedication to making this the most valuable free resource for oncology professionals 🌏 by bringing key insights from

My 54yr old cousin with prostate cancer wants a normal life again. New research shows cancer patients with better health literacy have significantly improved work ability during rehab—key for both economic & quality of life outcomes. #ReturnToWork #SurvivorshipCare

June is National Cancer Survivors Month! We celebrate 18M+ survivors whose journey continues beyond treatment. Health literacy empowers survivors to manage side effects, navigate emotional challenges, and address recurrence fears. Their resilience inspires us all.

Health literacy can be a lifesaver—literally. When patients understand their care, outcomes improve, especially in oncology. Empowered patients ask better questions, adhere to treatments, and navigate their cancer journey with confidence. It’s time to prioritize education🩺📚

Despite oncologist shortages and limited time for innovation, many still support patients beyond clinic walls. David Einstein exemplifies this by advising Boston Prostate Cancer Support Group, translating research into empowerment. Clinical expertise meets community!

Hmmm, imagine if health literacy in cancer care was this simple… or can it be? Sometimes just changing the words can make a lifestyle change feel more doable for everyone. #HealthLiteracy #PlainLanguage

Health literacy isn’t just about reading-it’s about understanding complex terms like “biopsy,” “Gleason score,” and “metastasis.” Clear communication can empower patients to make informed decisions. #HealthLiteracy #ProstateCancer

Did you know? Understanding nutrition’s role in prostate cancer can influence outcomes. For example, diets rich in tomatoes (lycopene) may be linked to lower risk, but many patients never hear this! #KnowledgeIsPower

In reading many of the abstracts and watching the amazing presentations at ASCO, I’m reminded that access to clinical trials is still a privilege for too few. We need to break down barriers for underserved communities. #HealthEquity

🎯 This #ASCO25 breakthrough hits close to home: ^177Lu-PSMA-617 could help patients like my cousin in 🇱🇰 who couldn't access ADT and was told he'd need castration. This "smart bomb" therapy offers new hope—delaying hormone treatment with better quality of life. #ProstateCancer

Health literacy isn’t just about reading pamphlets—it’s about empowering patients to understand and advocate for their care. #ASCO25 #HealthLiteracy

Access gap: Black men 56% less likely to receive novel hormonal agents (Medicare data) and 32% less likely to get combination therapies. Groundbreaking treatments aren't reaching those who need them most. #ProstateCancer #HealthcareInequity

The disparities in biomarker testing access are real. Too many patients are missing out on precision medicine because of where they live. #ASCO25

Struck by how funding for cancer research doesn’t always match mortality rates. Some of the deadliest cancers get the least support. #ASCO25 #HealthEquity

Still seeing too many assumptions made about who is “at risk.” Bias in care delivery perpetuates disparities. #ASCO25

Inspired by the ATOMIC study at ASCO: Patients like Maria, living with stage III dMMR colon cancer, are at the heart of research advances. Grateful for the dedication of trial teams working to expand options and hope for families everywhere. #ColorectalCancer #Immunotherapy

Machine Learning–Based Approach Improves Outcome Prediction vs Individual Biomarkers in RCC David Braun Yale Cancer Center #RCC onclive.com/view/machine-l…

State of the Art: Personalizing Treatment for Patients With Metastatic Castration-Resistant Prostate Cancer by Ruben Raychaudhuri et al. Learn more: brnw.ch/21wTdI3 #ASCOEdBook #ASCO25 #mCRCPC #pcsm

Congratulations.